| Symbol |
Name |
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
BMP1
|
bone morphogenetic protein 1
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMP7
|
bone morphogenetic protein 7
|
|
CALR
|
calreticulin
|
|
CD14
|
CD14 molecule
|
|
CD177
|
CD177 molecule
|
|
CD34
|
CD34 molecule
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEACAM8
|
carcinoembryonic antigen-related cell adhesion molecule 8
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
ENG
|
endoglin
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ETV6
|
ets variant 6
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
FKBP5
|
FK506 binding protein 5
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
HDAC11
|
histone deacetylase 11
|
|
HDAC9
|
histone deacetylase 9
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
JAK2
|
Janus kinase 2
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KRT7
|
keratin 7, type II
|
|
LDHA
|
lactate dehydrogenase A
|
|
LDHB
|
lactate dehydrogenase B
|
|
LOX
|
lysyl oxidase
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
LOXL2
|
lysyl oxidase-like 2
|
|
LTBP1
|
latent transforming growth factor beta binding protein 1
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
NFE2
|
nuclear factor, erythroid 2
|
|
NOG
|
noggin
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
ORAI2
|
ORAI calcium release-activated calcium modulator 2
|
|
ORAI3
|
ORAI calcium release-activated calcium modulator 3
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PHF20
|
PHD finger protein 20
|
|
PML
|
promyelocytic leukemia
|
|
PRG2
|
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)
|
|
PTH
|
parathyroid hormone
|
|
RARB
|
retinoic acid receptor, beta
|
|
RUNX1
|
runt-related transcription factor 1
|
|
SLCO2A1
|
solute carrier organic anion transporter family, member 2A1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STIM1
|
stromal interaction molecule 1
|
|
STIM2
|
stromal interaction molecule 2
|
|
TAC1
|
tachykinin, precursor 1
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THBS1
|
thrombospondin 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TP53
|
tumor protein p53
|
|
TPO
|
thyroid peroxidase
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
|
TRPC4
|
transient receptor potential cation channel, subfamily C, member 4
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
ZFPM1
|
zinc finger protein, FOG family member 1
|
